Edwards Lifesciences (EW) Tops Q2 EPS by 8c; Lifts FY15 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Shipping stocks on fire — but cracks are forming in the rate rally
Edwards Lifesciences (EW) PT, Estimates Lifted at Piper Jaffray Amid Solid Q2
July 29, 2015 9:02 AM EDTPiper Jaffray analyst Brooks West reiterated an Overweight rating and boosted estimates and his price target on Edwards Lifesciences (NYSE: EW) to $181.00 (from $170.00) following Q2 results.
West commented, "Edwards reported Q2 revenues of $616.8M, beating our Street high estimate of $615.5M and consensus... More
